|
1
|
Schweitz H, Vigne P, Moinier D, Frelin C
and Lazdunski M: A new member of the natriuretic peptide family is
present in the venom of the green mamba (Dendroaspis angusticeps).
J Biol Chem. 267:13928–13932. 1992.PubMed/NCBI
|
|
2
|
Schirger JA, Heublein DM, Chen HH, et al:
Presence of Dendroaspis natriuretic peptide-like immunoreactivity
in human plasma and its increase during human heart failure. Mayo
Clin Proc. 74:126–130. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lisy O, Lainchbury JG, Leskinen H and
Burnett JC Jr: Therapeutic actions of a new synthetic vasoactive
and natriuretic peptide, dendroaspis natriuretic peptide, in
experimental severe congestive heart failure. Hypertension.
37:1089–1094. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Woodard GE, Rosado JA and Brown J:
Dendroaspis natriuretic peptide-like immunoreactivity and its
regulation in rat aortic vascular smooth muscle. Peptides.
23:23–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen HH, Lainchbury JG and Burnett JC:
Natriuretic peptide receptors and neutral endopeptidase in
mediating the renal actions of a new therapeutic synthetic
natriuretic peptide dendroaspis natriuretic peptide. J Am Coll
Cardiol. 40:1186–1191. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lainchbury JG, Lisy O, Burnett JC Jr,
Meyer DM and Redfield MM: Actions of a novel synthetic natriuretic
peptide on hemodynamics and ventricular function in the dog. Am J
Physiol. 282:R993–R998. 2002.
|
|
7
|
Singh G, Kuc RE, Maguire JJ, Fidock M and
Davenport AP: Novel snake venom ligand dendroaspis natriuretic
peptide is selective for natriuretic peptide receptor-A in human
heart: downregulation of natriuretic peptide receptor-A in heart
failure. Circ Res. 99:183–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim SM, Kim YA, Kim SY, Kim SH, Cho KW and
Kim SZ: Presence of dendroaspis natriuretic peptide and its binding
to NPR-A receptor in rabbit kidney. Regulatory peptides. 167:42–49.
2011. View Article : Google Scholar
|
|
9
|
Kim SM, Kim SY, Kim SH, Cho KW and Kim SZ:
Renal actions of dendroaspis natriuretic peptide in rabbits.
Peptides. 33:59–66. 2012. View Article : Google Scholar
|
|
10
|
Kim SM, Kim SY, Kim SH and Kim SZ:
Dendroaspis natriuretic peptide is degraded by a metalloproteinase
in the rat kidney. Mol Med Rep. 9:1037–1043. 2014.
|
|
11
|
Dronavalli S, Duka I and Bakris GL: The
pathogenesis of diabetic nepthropathy. Nat Clin Pract Endocrinol
Metab. 4:444–452. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Walther T, Heringer-Walther S, Tschope R,
Reinecke A, Schultheiss HP and Tschope C: Opposite regulation of
brain and C-type natriuretic peptides in the
streptozotocin-diabetic cardiopathy. J Mol Endocrinol. 24:391–395.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Obineche EN, Adeghate E, Chandranath IS,
Benedict S, Al Gafri LS and Adem A: Alterations in atrial
natriuretic peptide and its receptors in streptozotocin-induced
diabetic rat kidneys. Mol Cell Biochem. 261:3–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ortola FV, Ballermann BJ, Anderson S,
Mendez RE and Brenner BM: Elevated plasma atrial natriuretic
peptide levels in diabetic rats. Potential mediator of
hyperfiltration. J Clin Invest. 80:670–674. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jacobs EM, Vervoort G, Branten AJ, Klasen
I, Smits P and Wetzels JF: Atrial natriuretic peptide increases
albuminuria in type I diabetic patients: evidence for blockade of
tubular protein reabsorption. Eur J Clin Invest. 29:109–115. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sawicki PT, Heinemann L, Rave K, Hohmann A
and Berger M: Atrial natriuretic factor in various stages of
diabetic nephropathy. J Diabet Complications. 2:207–209. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Benigni A, Perico N, Dadan J, et al:
Functional implications of decreased renal cortical atrial
natriuretic peptide binding in experimental diabetes. Circ Res.
66:1453–1460. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sechi LA, Valentin JP, Griffin CA, et al:
Receptors for atrial natriuretic peptide are decreased in the
kidney of rats with streptozotocin-induced diabetes mellitus. J
Clin Invest. 95:2451–2457. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Christoffersen C, Bartels ED and Nielsen
LB: Heart specific up-regulation of genes for B-type and C-type
natriuretic peptide receptors in diabetic mice. European journal of
clinical investigation. 36:69–75. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cho KW, Kim SH, Kim CH and Seul KH:
Mechanical basis of ANP secretion in beating atria: atrial stroke
volume and ECF translocation. Am J Physiol. 268:R1129–R1136.
1995.PubMed/NCBI
|
|
21
|
Kim SZ, Cho KW and Kim SH: Modulation of
endocardial natriuretic peptide receptors in right ventricular
hypertrophy. Am J Physiol. 277:H2280–H2289. 1999.PubMed/NCBI
|
|
22
|
Kim SZ, Kim SH, Park JK, Koh GY and Cho
KW: Presence and biological activity of C-type natriuretic
peptide-dependent guanylate cyclase-coupled receptor in the penile
corpus cavernosum. J Urol. 159:1741–1746. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Munson PJ and Rodbard D: Ligand: a
versatile computerized approach for characterization of
ligand-binding systems. Anal Biochem. 107:220–239. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu YS, Lu HL, Huang X, Liu DH, Meng XM,
Guo X, Kim YC and Xu WX: Diabetes-induced loss of gastric ICC
accompanied by up-regulation of natriuretic peptide signaling
pathways in STZ-induced diabetic mice. Peptides. 40:104–111. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu SQ, Kwan CY and Tang F:
Streptozotocin-induced diabetes has differential effects on atrial
natriuretic peptide synthesis in the rat atrium and ventricle: a
study by solution-hybridization-RNase protection assay.
Diabetologia. 41:660–665. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai GY, Piao FL, Kim SY, Yuan K, Kim SZ
and Kim SH: Augmentation of insulin-stimulated ANP release through
tyrosine kinase and PI 3-kinase in diabetic rats. Peptides.
27:2756–2763. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chinkers M, Garbers DL, Chang MS, et al: A
membrane form of guanylate cyclase is an atrial natriuretic peptide
receptor. Nature. 338:78–83. 1989. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Porter JG, Wang Y, Schwartz K, et al:
Characterization of the atrial natriuretic peptide clearance
receptor using a vaccinia virus expression vector. J Biol Chem.
263:18827–18833. 1988.PubMed/NCBI
|
|
29
|
Maack T, Suzuki M, Almeida FA, et al:
Physiological role of silent receptors of atrial natriuretic
factor. Science. 238:675–678. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Koller KJ, Lowe DG, Bennett GL, et al:
Selective activation of the B natriuretic peptide receptor by
C-type natriuretic peptide (CNP). Science (New York, NY).
252:120–123. 1991. View Article : Google Scholar
|
|
31
|
Suga S, Nakao K, Hosoda K, et al: Receptor
selectivity of natriuretic peptide family, atrial natriuretic
peptide, brain natriuretic peptide, and C-type natriuretic peptide.
Endocrinology. 130:229–239. 1992.PubMed/NCBI
|
|
32
|
Johns DG, Ao Z, Heidrich BJ, et al:
Dendroaspis natriuretic peptide binds to the natriuretic peptide
clearance receptor. Biochem Biophys Res Commun. 358:145–149. 2007.
View Article : Google Scholar : PubMed/NCBI
|
